Yalcin, A. D., Bisgin, A., Kargi, A., & Gorczynski, R. M. (2012). Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: Its relation to omalizumab treatment. International Scientific Literature, Inc.
استشهاد بنمط شيكاغوYalcin, Arzu Didem, Atil Bisgin, Aysegul Kargi, و Reginald M. Gorczynski. Serum-soluble TRAIL Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment. International Scientific Literature, Inc, 2012.
MLA استشهادYalcin, Arzu Didem, Atil Bisgin, Aysegul Kargi, و Reginald M. Gorczynski. Serum-soluble TRAIL Levels in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment. International Scientific Literature, Inc, 2012.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.